Article Figures & Data
Tables
Patient Characteristic Erector Spinae Plane (n = 36) Control (n = 108) P Value Age, y 62.5 (9.4) 62.9 (1.3) 0.840 Body mass index 29.5 (5.1) 31.5 (6.2) 0.092 Sex Male 19 (52.8%) 51 (47.2%) 0.564 Female 17 (47.2%) 57 (52.8%) Smoking 5 (13.9%) 25 (23.1%) 0.236 Diabetes 10 (27.8%) 26 (24.1%) 0.657 Rheumatoid arthritis 6 (16.7%) 1 (0.9%) <0.001a Drug abuse history 2 (5.6%) 6 (5.6%) >0.99 Previous pain management 13 (36.1%) 54 (50.0%) 0.148 Number of levels 1.0 (1.0–2.0) 1.5 (1.0–2.0) 0.702 Note: Data presented as number (%), mean (SD), or median (interquartile range).
↵a Statistically significant (P ≤ 0.05).
Outcome Measure Erector Spinae Plane (n = 36) Control (n = 108) P Value Total MME POD 0 to 2 123.7 (69.2–143.9) 141.2 (75.8–185.5) 0.050a Total MME POD 0 to 5 149.8 (80.0–241.1) 188.3 (121.3–330.2) 0.020a Length of stay, d 3.0 (2.0–4.0) 4.0 (3.0–6.0) 0.005a Abbreviations: MME, morphine milligram equivalents; POD, postoperative day.
Note: Data presented as median (interquartile range).
↵a Statistically significant (P ≤ 0.05)
Pain VAS Follow-up ESP
(n = 36)Control
(n = 108)P Value ESP Control POD 0 36 (100%) 106 (98.1%) 7.0 (6.0–8.0) 8.0 (6.0–9.0) 0.349 POD 1 35 (97.2%) 105 (97.2%) 8.0 (6.0–9.0) 8.0 (6.0–9.0) 0.862 POD 2 30 (83.3%) 97 (89.8%) 7.0 (4.7–8.2) 7.0 (5.0–8.0) 0.911 POD 3 23 (63.8%) 78 (72.2%) 7.0 (3.0–8.0) 7.0 (6.0–8.2) 0.227 POD 4 13 (36.1%) 59 (54.6%) 5.0 (3.5–7.5) 8.0 (7.0–9.0) 0.009a POD 5 4 (11.1%) 42 (38.8%) 7.0 (1.5–9.5) 7.0 (5.0–8.0) 0.955 Weeks 2 to 4 34 (94.4%) 89 (82.4%) 4.0 (2.0–6.0) 5.0 (2.0–7.0) 0.703 Months 2 to 3 33 (91.6%) 80 (74.0%) 2.0 (0.0–5.0) 4.0 (1.0–6.0) 0.075 Month 6 22 (61.1%) 63 (58.3%) 3.0 (0.0–5.5) 4.0 (0.0–6.0) 0.218 1 Year 13 (36.1%) 44 (40.7%) 3.0 (0.0–5.5) 5.0 (2.0–7.0) 0.050a Abbreviations: ESP, erector spinae plane; POD, postoperative day; VAS, visual analog scale.
Note: Data presented as number (%) and median (interquartile range).
↵a Statistically significant (P ≤ 0.05).